|
US5308850A
(en)
|
1991-09-30 |
1994-05-03 |
Merck Frosst Canada, Inc. |
(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
US5290798A
(en)
|
1991-09-30 |
1994-03-01 |
Merck Frosst Canada, Inc. |
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
JPH06145150A
(ja)
|
1992-11-09 |
1994-05-24 |
Kyowa Hakko Kogyo Co Ltd |
イミダゾール誘導体
|
|
DE69728688T2
(de)
|
1996-11-19 |
2004-08-19 |
Amgen Inc., Thousand Oaks |
Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
|
|
AU4967797A
(en)
|
1996-11-19 |
1998-06-10 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzofuran derivatives
|
|
WO1998057931A2
(en)
|
1997-06-19 |
1998-12-23 |
Sepracor Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
PL198030B1
(pl)
|
1997-10-24 |
2008-05-30 |
Nissan Chemical Ind Ltd |
Związek sulfamoilowy oraz rolniczy i ogrodniczy fungicyd
|
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
CA2386750A1
(en)
|
1999-10-22 |
2001-05-03 |
Merck & Co. Inc. |
Pharmaceuticals for treating obesity
|
|
AU2001280187A1
(en)
|
2000-08-28 |
2002-03-13 |
Toray Industries, Inc. |
Cyclic amine derivatives
|
|
AU9619301A
(en)
|
2000-10-20 |
2002-04-29 |
Biovitrum Ab |
2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
|
|
BR0115102B1
(pt)
|
2000-11-02 |
2013-11-26 |
|
Compostos 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis e composição compreendendo os mesmos
|
|
US6503907B2
(en)
*
|
2000-11-28 |
2003-01-07 |
Hoffmann-La Roche Inc. |
Indole and dihydroindole derivatives
|
|
BR0116323A
(pt)
|
2000-12-22 |
2003-10-14 |
Wyeth Corp |
Compostos de heterociclilindazol e -azaindazol como ligandos de 5-hidroxitriptamina-6
|
|
WO2003082802A1
(en)
|
2002-03-27 |
2003-10-09 |
Smithkline Beecham Corporation |
Acid and ester compounds and methods of using the same
|
|
DE60309598T2
(de)
|
2002-06-24 |
2007-09-13 |
Schering Corp. |
Als histamin-h3-antagonisten geeignete indolderivate
|
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
|
GB0323845D0
(en)
*
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
BRPI0507626A
(pt)
*
|
2004-02-11 |
2007-07-03 |
Irm Llc |
compostos e composiçoes como moduladores de lxr
|
|
WO2005085188A2
(en)
|
2004-03-02 |
2005-09-15 |
Compass Pharmaceuticals Llc |
Compounds and methods for anti-tumor therapy
|
|
PT1756096E
(pt)
*
|
2004-05-03 |
2009-10-16 |
Hoffmann La Roche |
Derivados de indolilo como moduladores do receptor x do fígado
|
|
WO2005113499A1
(ja)
*
|
2004-05-20 |
2005-12-01 |
Sankyo Company, Limited |
インドール化合物
|
|
AU2005271737A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Wyeth |
Indazoles useful in treating cardiovascular diseases
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
US20080319044A1
(en)
|
2004-11-01 |
2008-12-25 |
Nuada, Llc |
Compounds and Methods of Use Thereof
|
|
WO2006109633A1
(ja)
*
|
2005-04-07 |
2006-10-19 |
Daiichi Sankyo Company, Limited |
置換インドール化合物
|
|
FR2886293B1
(fr)
*
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
TW200745031A
(en)
*
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
|
BRPI0620386A2
(pt)
|
2005-12-21 |
2011-12-20 |
Schering Corp |
composição compreendendo a combinação de um antagonista de h3/agonista inverso e um supressor de apetite e uso da referida composição
|
|
ATE526327T1
(de)
|
2006-07-06 |
2011-10-15 |
Abbott Healthcare Products Bv |
Azaindolderivate mit einer kombination eines teilweisen agonismus am nikotinischen acetylcholinrezeptor und einer inhibierung der dopaminwiederaufnahme
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
EP2155724A1
(en)
|
2007-03-23 |
2010-02-24 |
Abbott GmbH & Co. KG |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
CN101641348B
(zh)
|
2007-03-30 |
2014-09-10 |
霍夫曼-拉罗奇有限公司 |
咪唑烷酮衍生物
|
|
GB0708141D0
(en)
|
2007-04-26 |
2007-06-06 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
|
EP2197842B1
(en)
|
2007-08-29 |
2012-05-23 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
|
CA2697500A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2,3-substituted azaindole derivatives for treating viral infections
|
|
EP2222672B1
(en)
|
2007-11-16 |
2013-12-18 |
Merck Sharp & Dohme Corp. |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
|
CA2705586A1
(en)
|
2007-11-16 |
2009-05-22 |
Schering Corporation |
3-heterocyclic substituted indole derivatives and methods of use thereof
|
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
EP2210891A1
(en)
*
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
|
EP2245936A1
(en)
|
2009-04-27 |
2010-11-03 |
Bayer CropScience AG |
Use of 4-aza indole derivatives for the reduction of mycotoxin contamination
|
|
JP5912078B2
(ja)
|
2009-06-08 |
2016-04-27 |
アクセルロン ファーマ， インコーポレイテッド |
熱発生性脂肪細胞を増加させるための方法
|
|
EP2731436B1
(en)
|
2011-07-15 |
2017-03-08 |
VIIV Healthcare UK Limited |
2-(pyrrolo[2,3-b]pyridine-5-yl)-2-(t-butoxy)-acetic acid derivatives as hiv replication inhibitors for the treatment of aids
|
|
WO2013028999A1
(en)
|
2011-08-24 |
2013-02-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
|
|
MY192815A
(en)
|
2011-12-22 |
2022-09-09 |
Connexios Life Sciences Pvt Ltd |
Derivatives of aza adamantanes and uses thereof
|
|
KR20130142801A
(ko)
|
2012-06-20 |
2013-12-30 |
안국약품 주식회사 |
１１β－ＨＳＤ１ 효소의 억제활성을 갖는 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
WO2014065575A1
(ko)
*
|
2012-10-25 |
2014-05-01 |
주식회사유한양행 |
4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
|
|
WO2014085453A2
(en)
|
2012-11-29 |
2014-06-05 |
The Scripps Research Institute |
Small molecule lxr inverse agonists
|
|
EP2968275B1
(en)
*
|
2013-03-15 |
2017-11-29 |
Bristol-Myers Squibb Company |
Lxr modulators
|
|
EP2990403A1
(en)
|
2014-08-29 |
2016-03-02 |
Novartis Tiergesundheit AG |
Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
|
|
JP2018500388A
(ja)
|
2014-11-18 |
2018-01-11 |
ラットガーズ、ザ ステート ユニバーシティ オブ ニュージャージー |
代謝疾患及び癌の治療のための、新規ミトコンドリアアンカップラー
|
|
AR103232A1
(es)
|
2014-12-22 |
2017-04-26 |
Bristol Myers Squibb Co |
ANTAGONISTAS DE TGFbR
|
|
FR3037959B1
(fr)
*
|
2015-06-23 |
2017-08-04 |
Servier Lab |
Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
CN109415363B
(zh)
|
2016-05-18 |
2021-07-20 |
罗格斯，新泽西州立大学 |
用于治疗代谢疾病和癌症的新的线粒体解偶联剂
|
|
UY37659A
(es)
*
|
2017-04-10 |
2018-10-31 |
Phenex Fxr Gmbh |
Moduladores del receptor x del hígado (lxr)
|
|
TWI683808B
(zh)
*
|
2017-07-18 |
2020-02-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有胺或(硫)醯胺之lxr調節劑
|
|
CN118791407A
(zh)
|
2018-05-22 |
2024-10-18 |
奥索生物公司 |
亚磺酰基氨基苯甲酰胺以及磺酰基氨基苯甲酰胺衍生物
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
WO2020257283A1
(en)
|
2019-06-18 |
2020-12-24 |
Mitopower Llc |
Nicotinyl riboside compounds and their uses
|
|
WO2024097897A1
(en)
|
2022-11-03 |
2024-05-10 |
Orsobio, Inc. |
Lxr modulators with bicyclic core moiety for treating dyslipidemias
|